Shaukat Ali, MD
Nephrology · Paducah, KYNPI 1700956844
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,759 of the $8,845 with a category attached, or 87.7%. It is spread thinly across 38 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among nephrology clinicians in KY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 470 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Vifor Pharma, Inc.$984
- Fresenius USA Marketing, Inc.$897
- OPKO Pharmaceuticals, LLC$880
- Bayer$515
- Akebia Therapeutics Inc$514
- plus $4K from 32 others
Across 1 payment — averaging $68.04 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$68
What the payments were for
- Food & beverage$7,75988%
- Education$1,08612%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$8,845 in reported general payments places this provider in the 90th percentile of 165 nephrology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 609 | $417,106 |
| JardianceEmpagliflozin | 188 | $146,949 |
| XphozahTenapanor Hcl | 41 | $140,864 |
| VelphoroSucroferric Oxyhydroxide | 20 | $84,428 |
| RayaldeeCalcifediol | 51 | $75,268 |
| AuryxiaFerric Citrate | 26 | $52,930 |
| KerendiaFinerenone | 61 | $44,909 |
| DapagliflozinDapagliflozin Propanediol | 42 | $19,978 |
| VeltassaPatiromer Calcium Sorbitex | 19 | $18,803 |
| LokelmaSodium Zirconium Cyclosilicate | 18 | $17,129 |
| XareltoRivaroxaban | 13 | $7,041 |
| Sevelamer Carbonate | 45 | $6,412 |
| Nifedipine ErNifedipine | 121 | $3,826 |
| Midodrine Hcl | 33 | $3,541 |
| Calcitriol | 333 | $2,571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Lokelma | $1,398 | $434,235627 claims |
| Boehringer IngelheimJardiance | $15 | $146,949188 claims |
| Fresenius USA Marketing, Inc.Velphoro | $897 | $84,42820 claims |
| OPKO Pharmaceuticals, LLCRayaldee | $880 | $75,26851 claims |
| Akebia Therapeutics IncAuryxia | $514 | $52,93026 claims |
| BayerKerendia | $515 | $44,90961 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 165 nephrology providers in Kentucky.
Other nephrology in Paducah
- Jonathan WilkersonPaducah$9K
- Hisham Abu FarsakPaducah$4K
- Danny WooLouisville$427K
- Dawn CasterLouisville$193K
- Javier Neyra LozanoLexington$181K
- Kurt SowersHazard$119K
- Nizar AttallahLouisville$113K
- Ravinder BhagrathPikeville$84K
- Shafic Abdul Wahab El HindiLouisville$45K
- George AronoffLouisville$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.